BamSEC and AlphaSense Join Forces
Learn More

Dermata Therapeutics Inc. – Indentures

NASDAQ: DRMA    
Share price (3/24/26): $1.55    
Market cap (3/24/26): $4.395 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 8-K 16 pages Placement Agent Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 16 pages Series [C]/[D] Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.6
from S-3 50 pages Dermata Therapeutics, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.5
from S-3 54 pages Dermata Therapeutics. Inc., as Issuer and [●], as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.2
from 8-K 16 pages Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages [Series a/Series B] Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.12
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 18 pages Placement Agent Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 19 pages Pre-Funded Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 19 pages Placement Agent Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 19 pages Series a / Series B Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Pre-Funded Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 18 pages Placement Agent Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages [Series a/Series B] Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.12
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 20 pages Placement Agent Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages [Series a/Series B] Common Stock Purchase Warrant Dermata Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 17 pages Placement Agent Common Stock Purchase Warrant Dermata Therapeutics, Inc. Warrant Shares: Issue Date: May 26, 2023 Initial Exercise Date: May 26, 2023
12/34/56